P46375 8th Annual Cell Line Development and Engineering Asia
Download Brochure Request

Register your interest


Register your interest


8th Annual Cell Line Development and Engineering Asia

15 – 16 May 2019, Shanghai Marriott Hotel Parkview, China

Register Your Interest Download Brochure



The global market size for cell line development is expected to exceed USD 7.5 billion by 2024. Some key market drivers include the demand for cell therapies, growing oncology market, increasing demand for vaccines and monoclonal antibodies, and continued growth in the vaccine market.

Aimed at providing a commercial snapshot of new market opportunities, yet retaining its focus on scientific and technical best practice use cases, the 8th Annual Cell Line Development & Engineering Asia summit will continue to provide unique learning and sharing opportunities for the industry.

Discussion themes

  • Impact of the surging biologics and cell therapy market on cell line development
  • Cell line market trends by source – mammalian and non-mammalian, and influencing factors
  • Market outlook for cell lines across drug discovery, bioproduction, toxicity testing, and tissue engineering
  • CAR-T cell development and manufacturing
  • Growth prospects in the primary cell line and tissue engineering
  • Use cases of 3D cell culture in primary cell lines
  • The growing use of reagents and media, and technical best practice
  • In-source or out-source cell line development
  • Best practice to ensure clonality in new cell lines and legacy cell lines
  • Procs and cons of generation sequencing (NGS) for proving the clonality of legacy production cell lines
  • The use of synthetic biology to help understand success and failure in cell line development
  • CRIPSR in cell line development
  • Comparingculture methods – batch, fedbatch, and perfusion processes
  • Tailoring cell line development programs for your project

Part of

5th Annual BioPharma Development and Production Week »

With demonstrated success year on year, IBC’s BioPharma Development and Production Week in China enjoys unparalleled industry support. Known for generating knowledge, creating business opportunities, and bringing innovative ideas to the table, the BDP Week is now more impactful than ever with 5 high-level conferences, learning seminars, focused trade shows and business matching to boot.

Co located conferences

The BDP Party!

When: Wednesday, 15 May 2019 at 6.30pm
Where: Shanghai City Bistro, Level 1, Shanghai Marriott Parkview Hotel
Cost: CNY 350 / USD 50 net (inclusive of buffet dinner and free flow wine / beer)

  • Registration is not limited to conference participants and we encourage all who are in the BDP industry to attend.
  • Dinner will only proceed when we have reached 100 participants.
  • Payment is only required when the dinner is confirmed.
  • Participants list for the dinner will be made available online once the registration reaches 100 participants.

CNY Pricing

  • 2 Day Conference: CNY 6,500
  • Group of 2 or more delegates: CNY 5,000
  • Group of 4 or more delegates: CNY 4,500
  • Pre Conference Workshop: CNY 1,000
  • Gala Dinner: CNY 350


Partnership and Profile Building Opportunities are Now Available!
Contact us today to find out how you can position your company as a market leader at this event, and to explore the range of branding and marketing opportunities available.


Judith Li

Partner, Lilly Asia Ventures, Hong Kong

Feng Tao

Founding Partner, Biotrack Capital, China

He Ting

Chief Executive Officer, ImmunoChina, China

Dong Wei

CEO, Edigene, China

Peter Luo

CEO, Adagene Pharma, China

Jonathan Zhao 4th Annual Bioprocess and Technology 2018

Jonathan Zhao

Co-Founder and Executive Chairman, TRANSCENTA HOLDING, China

Thomas Kelly

Scientist, Cell & Developability Sciences, Pharmaceutical Development & Manufacturing Sciences (PDMS), Janssen R&D, U.S.

George Hutchinson

Head of Global Distribution, Solentim, UK

Dr. John Yan

Applications Scientist, ProZyme, U.S.

Dr. Senyon Choe (Teddy)

Professor, Biology, University of California San Diego (UCSD), U.S. and President and Director of Joint Center for Biosciences, South Korea

Dr. Carolanne Doherty

Marketing & Sales Manager, Valitacell, Ireland

Dr. Ben Borgo

Associate Director, Assays, Reagents, and Software, Berkeley Lights, U.S.

Dr. Steve Oh

Institute Scientist and Director, Stem Cell Bioprocessing, Bioprocessing Technology Institute, A*STAR, Singapore

Dr. Dong-Yup Lee

Associate Professor, College of Engineering, Sung Kyun Kwan University (SKKU), South Korea

Ben Werdelmann

Director, Business Development and Applications, SYNENTEC GmbH, Germany

Dr. Fabian Stumpf

CMO, Cytena, Germany

Dr. Qinghai Zhao

Vice President, Technical Development and Manufacturing, Forty-Seven Inc. USA

Dr. Jerry Yang

Senior Vice President, Process & Product Development, Hangzhou JUST Biotherapeutics, China

Dr. Cuiyun Xu

Director, Upstream Process Development, Shanghai Henlius Biotech, Inc., China

Eric Chang

Head of Cell Line Development, JHL Biotech, Taiwan

Dr Jerry Dong

Vice President of CMC and Regulatory Affairs, Shanghai Henlius Biotech, Inc.

Chen-Yuan Lin

Ward Director and Attending Physician at the Division of Hematology and Oncology, China Medical University Hospital, Taiwan

Dr Lin Shiwen

Vice President of Downstream Process Development, WuXi Biologics, China

when & where

15 - 16 May 2019

Shanghai Marriott Hotel Parkview
333 Guang Zhong Road West, Jing’an District
Shanghai, 200072 China
Phone:+86 21 3669 8888
Fax:+86 21 3669 8668

Cartrina Wang 王洁琼 | Senior Sales Manager-EBC
T: 86 21 3669 8666 | M:13585605981



Still have a question?

Speaking Opportunities
Genevieve Lim
+65-6508 2472

Sponsorship Opportunities
Yvonne Leong
+65 6508 2489


Media & Association Partnership Opportunities
Eileen Tan
+65 6508 2462




Conference Partner Conference Partner


IBC Asia is Singapore's leading event organiser. We conceive, develop and promote our own B2B industry conferences and corporate training courses, and offer tailored managed event solutions.

Find out more

We are changing our brand to Informa Connect
Learn More